CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net income (loss)	$ 123,384	$ (126,329)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	768	419
Amortization of debt discount and issuance costs	6,935	34
(Decrease) increase in fair value of warrants	(9,826)	1,317
(Decrease) increase in fair value of SAFE notes	(209,291)	102,695
Impairment of prepaid launch costs	9,450	0
Stock-based compensation expense	11,187	1,642
Changes in operating assets and liabilities:
Prepaids and other current assets	(15,350)	(4,873)
Other non-current assets	(2,908)	360
Accounts payable	4,357	865
Accrued expenses	4,546	1,061
Other current liabilities	4,829	61
Contract liabilities	(1,071)	1,681
Lease liability and right of use asset	856	0
Other non-current liabilities	5	0
Net cash used in operating activities	(72,129)	(21,068)
Cash flows from investing activities:
Purchases of property, machinery and equipment	(2,835)	(1,245)
Purchases of intangible assets	(16)	(99)
Net cash used in investing activities	(2,852)	(1,345)
Cash flows from financing activities:
Proceeds from issuance of SAFE notes	30,853	44,650
Proceeds from issuance of loan payable	25,000	2,458
Proceeds from exercise of stock options	278	61
Payment of notes payable	0	(1,015)
Payment of debt issuance costs	(144)	(37)
Payment of warrant issuance costs	(31)	(1)
Payment for share repurchase	(40,000)	0
Proceeds from PIPE	110,000	0
Proceeds from issuance of common stock upon Merger	137,282	0
Payments for transaction costs	(32,585)	0
Net cash provided by financing activities	230,653	46,116
Increase in cash, cash equivalents and restricted cash	155,672	23,704
Cash, cash equivalents and restricted cash, beginning of period	23,520	13,002
Cash, cash equivalents and restricted cash, end of period	179,191	36,706
Supplemental disclosure of non-cash investing and financing activities
Issuance of common stock related to conversion of SAFE notes	136,001	0
Issuance of common stock related to exercise of warrant liabilities	7,001	0
Reclassification of deferred offering costs	6,203	0
Deferred offering costs in accounts payable and accrued expenses at period end	0	979
Assumption of merger warrants liability	31,225	0
Operating lease right-of-use assets in exchange for lease obligations	8,501	0
Supplemental disclosure of cash flow information
Cash paid for income taxes	1	1
Cash paid for interest	$ 1,750	$ 84